Condition: Chronic Obstructive Pulmonary Disease (COPD) · Sponsor: Sanofi
Study to evaluate the change of health-related quality of life, patient characteristics, efficacy and safety in Chronic Obstructive Pulmonary Disease (COPD) patients with Dupilumab therapy in a real-world setting over 24 months.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · Contact-US@sanofi.com
Always discuss trial participation with your own doctor first.
| Investigational Site Number: DE18 | Auerbach, Germany | Recruiting |
| Investigational Site Number: DE21 | Augsburg, Germany | Recruiting |
| Investigational Site Number: DE13 | Bad Homburg, Germany | Recruiting |
| Investigational Site Number: DE19 | Berlin, Germany | Recruiting |
| Investigational Site Number: DE02 | Berlin, Germany | Recruiting |
| Investigational Site Number: DE29 | Burgwedel, Germany | Recruiting |
| Investigational Site Number: DE01 | Darmstadt, Germany | Recruiting |
| Investigational Site Number: DE09 | Erkelenz, Germany | Recruiting |
| Investigational Site Number: DE06 | Flensburg, Germany | Recruiting |
| Investigational Site Number: DE08 | Fürstenwalde, Germany | Recruiting |
| Investigational Site Number: DE03 | Hamburg, Germany | Recruiting |
| Investigational Site Number: DE04 | Hamburg, Germany | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07052396